Skip to main content
Caplight Logo









Tetrous

Tetrous

Private
Sherman Oaks, CaliforniaHealthcare & Life Scienceshttps://tetrous.com/

Last Round

Seed Round

Apr 22, 2026

Est. Valuation

$31.5M

Total Funding Raised

$7.59M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Tetrous is a therapeutic devices company that provides regenerative medicine solutions for tissue repair in sports medicine applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

demineralized bone fiberregenerative medicineDBForthopedic implantsACL reconstructionorthobiologicsbone graftsports medicinesurgical scaffoldallograftorthopedic surgerybiologicsmedical devicetissue regeneration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tetrous Comparables

Compare Tetrous with similar companies based on industry and business-model similarity.

Tetrous comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atreon Orthopedics
83%
Isto Biologics
77%
Medtronic
74%

Tetrous Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 22, 2026
Series AMar 10, 2025
SeedDec 12, 2023

Key People

Founding team and executive leadership

Bradley Patt

Founder, CEO and Board Chairman

Founding Team

Tetrous Investors

Notable investors and investment history

Tetrous investors
InvestorRounds
ABT HealthcareSeries A
Australian BiotechnologiesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 50% QoQ, from 10 to 15 employees.

  • Jul 17, 2026

    Grew 56% QoQ, from 9 to 14 employees.

Tetrous Filings

Explore SEC and related filing metadata, where available.

Tetrous filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tetrous's valuation, stock price, and market status.

Is Tetrous a public or private company?

Tetrous is a private company.

What is the current stock price of Tetrous?

Tetrous is a private company with no public stock price. No recent secondary market data is available.

How much is Tetrous worth (valuation)?

Valuation information for Tetrous is not publicly available.

Can I buy Tetrous stock?

Tetrous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tetrous's last funding round?

Tetrous's most recent funding round was Seed Round on April 22, 2026.

Who are the main investors in Tetrous?

Key investors in Tetrous include ABT Healthcare, Australian Biotechnologies.

Will Tetrous IPO soon?

No public IPO plans have been announced for Tetrous.

How can I track Tetrous secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tetrous's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSherman Oaks, California
Employee Range14
Year Founded2019
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?